Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017–2022

Thumbnail Image

Date

2024-04-04

Authors

Dahl, Victor Naestholt
Butova, Tetiana
Rosenthal, Alex
Grinev, Alina
Gabrielian, Andrei
Vashakidze, Sergo
Shubladze, Natalia
Toxanbayeva, Bekzat
Chingissova, Lyailya
Crudu, Valeriu

Journal Title

Journal ISSN

Volume Title

Publisher

Centers for Disease Control and Prevention (CDC)

Abstract

In 2021, the World Health Organization recommended new extensively drug-resistant (XDR) and pre-XDR tuberculosis (TB) definitions. In a recent cohort of TB patients in Eastern Europe, we show that XDR TB as currently defined is associated with exceptionally poor treatment outcomes, considerably worse than for the former definition (31% vs. 54% treatment success).

Description

Keywords

drug-resistant tuberculosis, 2024а

Citation

Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017–2022 / V. N. Dahl, T. Butova, A. Rosenthal [et al.] // Emerging Infectious Diseases. ─ 2024. ─ № 30 (4). ─ P. 831─833.

Endorsement

Review

Supplemented By

Referenced By